At ENTrigue we are committed to developing innovative products that improve patient care in Otolaryngology. We begin by listening to surgeons and our colleagues in the field to identify opportunities for innovation. These insights help us rethink the possibilities in surgical efficiency and patient comfort. The result: innovative, practical products that are designed to simplify procedures for the surgeon and improve healing for the patient.
March 17, 2010—ENTrigue Biologics porfolio grows with the addition of Xenograft Pericardium. Now available in small and large sizes for ENT procedures!
March 3, 2010—The MediENT™ Middle Turbinate Implant has received CE mark and Health Canada license.
